Condition: Psychotic Disorders · Psychiatric Hospitalization · Prodromal Symptoms · Sponsor: Finnish Institute for Health and Welfare
This study aims to identify unusual experiences and psychiatric symptoms that indicate a heightened risk for severe mental disorders - especially psychoses. It is important to develop reliable questionnaire methods that are cost-effective in first-stage screening, leading to in-depth assessments and targeted care. However, existing psychosis-risk questionnaires are limited in content, intended for adults, and have been insufficiently tested for actual predictive value. Therefore we will collect a new, large dataset from an unselected group of adolescents entering psychiatric care in three major urban areas of Finland. Comprehensive national health care registers will be used to assess how well the selected experiences and symptoms predict the participants' mental health over the following few years.
This description comes directly from the study's public registry record.
Sebastian Therman, PhD · +358445405559 · Sebastian.Therman@THL.fi
Jaana Suvisaari, MD, PhD · +358295248539 · Jaana.Suvisaari@THL.fi
Always discuss trial participation with your own doctor first.
| HUS Helsinki University Hospital, adolescent psychiatry clinics | Helsinki, Finland | Not Yet Recruiting |
| Northern Ostrobothnia Hospital District, Adolescent Mental Health Clinic | Oulu, Finland | Recruiting |
| Pirkanmaa Hospital District, Tays Central Hospital, Adolescent psychiatry clinic | Tampere, Finland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03332966